<p>Strides Pharma Science on Tuesday said it has received US health regulator’s approval for its generic version of triamcinolone acetonide ointment used for treatment of various skin conditions.</p>.<p>The approval is granted to the company's step-down wholly-owned subsidiary, Strides Pharma Global, Singapore, by the United States Food and Drug Administration (USFDA) for triamcinolone acetonide ointment USP, 0.05 per cent, Strides Pharma Science said in a regulatory filing.</p>.<p>"The product is part of the niche and small volume product portfolio with limited competition in the US market," it added.</p>.<p>Citing IQVIA data, the company said the US market for triamcinolone acetonide ointment USP, 0.05 per cent, is approximately USD 15 million.</p>.<p>"The product will be manufactured at the company's flagship facility at Bengaluru and will be marketed by Strides Pharma in the US market," it added.</p>.<p>The company has 124 cumulative abbreviated new drug application filings with USFDA of which 86 have been approved and 38 are pending clearance. </p>
<p>Strides Pharma Science on Tuesday said it has received US health regulator’s approval for its generic version of triamcinolone acetonide ointment used for treatment of various skin conditions.</p>.<p>The approval is granted to the company's step-down wholly-owned subsidiary, Strides Pharma Global, Singapore, by the United States Food and Drug Administration (USFDA) for triamcinolone acetonide ointment USP, 0.05 per cent, Strides Pharma Science said in a regulatory filing.</p>.<p>"The product is part of the niche and small volume product portfolio with limited competition in the US market," it added.</p>.<p>Citing IQVIA data, the company said the US market for triamcinolone acetonide ointment USP, 0.05 per cent, is approximately USD 15 million.</p>.<p>"The product will be manufactured at the company's flagship facility at Bengaluru and will be marketed by Strides Pharma in the US market," it added.</p>.<p>The company has 124 cumulative abbreviated new drug application filings with USFDA of which 86 have been approved and 38 are pending clearance. </p>